Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.560
+0.020 (0.79%)
At close: Apr 28, 2026, 4:00 PM EDT
2.550
-0.010 (-0.38%)
After-hours: Apr 28, 2026, 6:08 PM EDT
Moleculin Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 9.12 | 8.79 | 10.02 | 11.54 | 8.39 | |
| Research & Development | 15.89 | 17.73 | 19.49 | 18.97 | 14.42 | |
| Operating Expenses | 25.1 | 26.64 | 29.63 | 30.64 | 22.97 | |
| Operating Income | -25.1 | -26.64 | -29.63 | -30.64 | -22.97 | |
| Interest & Investment Income | 0.11 | 0.55 | 1.37 | 0.24 | 0.31 | |
| Other Non Operating Income (Expenses) | -8.56 | 0.04 | -1.51 | 1.38 | 6.77 | |
| EBT Excluding Unusual Items | -33.56 | -26.05 | -29.77 | -29.03 | -15.89 | |
| Pretax Income | -33.56 | -26.05 | -29.77 | -29.03 | -15.89 | |
| Net Income | -33.56 | -26.05 | -29.77 | -29.03 | -15.89 | |
| Preferred Dividends & Other Adjustments | 0.1 | - | - | - | - | |
| Net Income to Common | -33.66 | -26.05 | -29.77 | -29.03 | -15.89 | |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 760.13% | 74.28% | 3.60% | 6.43% | 172.97% | |
| EPS (Basic) | -28.42 | -189.14 | -376.71 | -380.52 | -221.77 | |
| EPS (Diluted) | -28.42 | -189.14 | -376.71 | -380.52 | -221.77 | |
| Free Cash Flow | -22.74 | -23.88 | -23.72 | -27.71 | -18.97 | |
| Free Cash Flow Per Share | -19.19 | -173.36 | -300.10 | -363.22 | -264.69 | |
| EBITDA | -25.01 | -26.52 | -29.5 | -30.51 | -22.8 | |
| D&A For EBITDA | 0.09 | 0.13 | 0.13 | 0.13 | 0.16 | |
| EBIT | -25.1 | -26.64 | -29.63 | -30.64 | -22.97 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.